SANUWAVE Health (SNWV) Q2 FY26 earnings call

SANUWAVE Health reported record-setting growth in its recurring applicator business, reflecting robust demand for its Ultramist product. However, overall revenue declined due to significant cannibalization from used system sales and a challenging market for capital equipment. The company withdrew its FY26 revenue guidance amidst uncertainty surrounding proposed CMS reimbursement changes for Ultramist, which could negatively impact future pricing, though it plans to actively participate in the comment period.